Sophia D. Langlois
Director · Keenova Therapeutics plc
Individual
- 2025
- Jul 18, 2026
- 4
Filings (90d)
0
Purchases
0
Sales
0
Summary
Latest filing:
Sophia D. Langlois has 4 SEC Form 4 filings on record going back to 2025, most recently on 18 July 2026.
Recent transactions
2The latest 2 SEC Form 4 transactions reported by Sophia D. Langlois.
Most active insiders across the market
Sophia D. Langlois has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- J.H. Whitney Equity Partners VII, LLC - $169.58M in AVAH purchases and sales in the last 90 days
- Vyacheslav Kim - $158.37M in KSPI purchases and sales in the last 90 days
- John B. Hess - $157.37M in CVX purchases and sales in the last 90 days
- William D. Mosley - $150.90M in STX purchases and sales in the last 90 days
- ADVENT INTERNATIONAL, L.P. - $147.60M in LUNR purchases and sales in the last 90 days
- Xiaodong Li - $147.35M in SE purchases and sales in the last 90 days
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sophia D. Langlois?
Sophia D. Langlois is a corporate insider, tracked as Director. InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sophia D. Langlois last file a Form 4?
The most recent primary Form 4 on record is dated 18 July 2026, one of 4 filings going back to 2025.